Cargando…

Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism

The development of antitumor chemotherapy drugs remains a key goal for oncologists, and natural products provide a vast resource for anti-cancer drug discovery. In the current study, we found that the flavonoid dihydromyricetin (DHM) exhibited antitumor activity against liver cancer cells, including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qingyu, Liu, Jie, Liu, Bin, Xia, Juan, Chen, Nianping, Chen, Xiaofeng, Cao, Yi, Zhang, Chen, Lu, CaiJie, Li, Mingyi, Zhu, Runzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982169/ https://www.ncbi.nlm.nih.gov/pubmed/24717393 http://dx.doi.org/10.1038/srep04628

Ejemplares similares

Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells
por: Jiang, Lianggui, et al.
Publicado: (2015)

Dihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cells
por: LIU, JIE, et al.
Publicado: (2014)

Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway
por: LIU, BIN, et al.
Publicado: (2015)

Dihydromyricetin Reduced Bcl-2 Expression via p53 in Human Hepatoma HepG2 Cells
por: Wu, Shixing, et al.
Publicado: (2013)

Notch3 functions as a regulator of cell self-renewal by interacting with the β-catenin pathway in hepatocellular carcinoma
por: Zhang, Qingyu, et al.
Publicado: (2015)

A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells
por: Lin, Bin, et al.
Publicado: (2014)

ERRATUM: A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells
por: Liu, Bin, et al.
Publicado: (2015)

Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells
por: LIU, BIN, et al.
Publicado: (2016)

Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G(1)/S-phase cell cycle arrest and apoptosis through caspase/cyclin-CDK pathways
por: LIU, BIN, et al.
Publicado: (2014)

Diosmetin inhibits cell proliferation and induces apoptosis by regulating autophagy via the mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells
por: Liu, Jie, et al.
Publicado: (2016)

Dihydromyricetin functions as a tumor suppressor in hepatoblastoma by regulating SOD1/ROS pathway
por: Guo, Tong, et al.
Publicado: (2023)

Mechanism of Dihydromyricetin on Inflammatory Diseases
por: Sun, Yang, et al.
Publicado: (2022)

Oroxylin A Accelerates Liver Regeneration in CCI(4)-Induced Acute Liver Injury Mice
por: Zhu, Runzhi, et al.
Publicado: (2013)

The Versatile Effects of Dihydromyricetin in Health
por: Li, Hongliang, et al.
Publicado: (2017)

Diosmetin triggers cell apoptosis by activation of the p53/Bcl-2 pathway and inactivation of the Notch3/NF-κB pathway in HepG2 cells
por: Qiao, Jie, et al.
Publicado: (2016)

Expression of Wnt3a in hepatocellular carcinoma and its effects on cell cycle and metastasis
por: Lu, Caijie, et al.
Publicado: (2017)

Resveratrol induces cell cycle arrest via a p53-independent pathway in A549 cells
por: YUAN, LONG, et al.
Publicado: (2015)

Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9
por: LIU, JIE, et al.
Publicado: (2016)

Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells
por: Jiang, Lianggui, et al.
Publicado: (2021)

Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin
por: Zhang, Jingyao, et al.
Publicado: (2018)

Dihydromyricetin Improves Endothelial Dysfunction in Diabetic Mice via Oxidative Stress Inhibition in a SIRT3-Dependent Manner
por: Hua, Yu-Yun, et al.
Publicado: (2020)

Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis
por: Cheng, Quan-Cheng, et al.
Publicado: (2020)

Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin
por: Xu, Yingqi, et al.
Publicado: (2017)

Mechanisms of dihydromyricetin against hepatocellular carcinoma elucidated by network pharmacology combined with experimental validation
por: Zhang, Shuo, et al.
Publicado: (2023)

Research progress of dihydromyricetin in the treatment of diabetes mellitus
por: Wang, Ziyuan, et al.
Publicado: (2023)

Dihydromyricetin hexaacetate
por: Li, Wei, et al.
Publicado: (2010)

CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma
por: Dai, Wei, et al.
Publicado: (2016)

Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice
por: Wu, Bin, et al.
Publicado: (2017)

Anti-inflammatory effects of dihydromyricetin in a mouse model of asthma
por: Xu, Bin, et al.
Publicado: (2017)

Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice
por: Feng, Jie, et al.
Publicado: (2018)

Exploring the genes involved in biosynthesis of dihydroquercetin and dihydromyricetin in Ampelopsis grossedentata
por: Yu, Zheng-Wen, et al.
Publicado: (2021)

Identification of Hydroxylation Enzymes and the Metabolic Analysis of Dihydromyricetin Synthesis in Ampelopsis grossedentata
por: Zhang, Shuai, et al.
Publicado: (2022)

Dihydromyricetin Acts as a Potential Redox Balance Mediator in Cancer Chemoprevention
por: Chen, Liang, et al.
Publicado: (2021)

Dihydromyricetin promotes longevity and activates the transcription factors FOXO and AOP in Drosophila
por: Fan, Xiaolan, et al.
Publicado: (2020)

Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges
por: Zhang, Ruirui, et al.
Publicado: (2022)

Dihydromyricetin inhibits African swine fever virus replication by downregulating toll-like receptor 4-dependent pyroptosis in vitro
por: Chen, Yang, et al.
Publicado: (2023)

CDKN3 expression predicates poor prognosis and regulates adriamycin sensitivity in hepatocellular carcinoma in vitro
por: Dai, Wei, et al.
Publicado: (2020)

Dihydromyricetin induced lncRNA MALAT1-TFEB-dependent autophagic cell death in cutaneous squamous cell carcinoma
por: Tan, Miduo, et al.
Publicado: (2019)

Dihydromyricetin improves social isolation-induced cognitive impairments and astrocytic changes in mice
por: Watanabe, Saki, et al.
Publicado: (2022)

Molecular Level Insight Into the Benefit of Myricetin and Dihydromyricetin Uptake in Patients With Alzheimer’s Diseases
por: Liu, Miaomiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n212um9ronstmb81hmj33fls70